Mylan buspirone
Executive Summary
Generic equivalent of Bristol-Myers Squibb's BuSpar approved in 30 mg tablet form June 29. As the first company to file a paragraph IV certification, the company will receive 180-day exclusivity on the dosage form. Mylan will launch the anxiolytic in a few weeks